HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Constantinos Giaginis Selected Research

Eph Family Receptors (Eph Receptors)

2/2022EPHA2, EPHA4, and EPHA7 Expression in Triple-Negative Breast Cancer.
4/2016Clinical Significance of EphB4 and EphB6 Expression in Human Malignant and Benign Thyroid Lesions.
4/2014Ephrin receptor (Eph) -A1, -A2, -A4 and -A7 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.
2/2014Ephrin (Eph) receptor A1, A4, A5 and A7 expression in human non-small cell lung carcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients' survival.
9/2011Eph-A2 and Eph-A4 expression in human benign and malignant thyroid lesions: an immunohistochemical study.
6/2010Clinical significance of ephrin (eph)-A1, -A2, -a4, -a5 and -a7 receptors in pancreatic ductal adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Constantinos Giaginis Research Topics

Disease

54Neoplasms (Cancer)
01/2022 - 06/2006
11Adenocarcinoma
09/2017 - 06/2008
10Neoplasm Metastasis (Metastasis)
01/2022 - 10/2009
10Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2017 - 02/2011
5Breast Neoplasms (Breast Cancer)
02/2022 - 01/2012
5Carcinogenesis
10/2021 - 10/2015
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2017 - 02/2014
4Disease Progression
03/2017 - 06/2011
4Lymphatic Metastasis
01/2017 - 03/2010
4Pancreatic Neoplasms (Pancreatic Cancer)
02/2013 - 05/2009
3Carcinoma (Carcinomatosis)
10/2021 - 01/2016
3Inflammation (Inflammations)
06/2018 - 09/2014
3Colorectal Neoplasms (Colorectal Cancer)
09/2017 - 10/2009
3Atherosclerosis
05/2017 - 07/2011
3Colonic Neoplasms (Colon Cancer)
01/2015 - 02/2009
3Carotid Artery Diseases
10/2012 - 07/2010
2Infections
01/2021 - 03/2010
2Tongue Neoplasms (Tongue Neoplasm)
08/2012 - 02/2011
1Cognitive Dysfunction
04/2021
1Endometrial Neoplasms (Endometrial Cancer)
01/2021
1Dental Plaque
07/2019
1Hypoxia (Hypoxemia)
03/2019
1Rectal Neoplasms (Rectal Cancer)
03/2019
1Renal Cell Carcinoma (Grawitz Tumor)
11/2018
1Skin Diseases (Skin Disease)
06/2018
1Chronic Disease (Chronic Diseases)
06/2018
1Metabolic Syndrome (Dysmetabolic Syndrome X)
06/2018
1Premenstrual Syndrome (Premenstrual Tension)
06/2018
1Fatty Liver
06/2018
1Obesity
06/2018
1Arthritis (Polyarthritis)
06/2018
1Gestational Weight Gain
02/2018
1Drug-Related Side Effects and Adverse Reactions
01/2017
1Necrosis
01/2017
1Margins of Excision
01/2016
1Vulvar Diseases
01/2016
1Intrahepatic Cholestasis of Pregnancy
04/2015
1Gallstones (Gallstone)
04/2015

Drug/Important Bio-Agent (IBA)

31Proteins (Proteins, Gene)FDA Link
10/2021 - 02/2009
13Biomarkers (Surrogate Marker)IBA
11/2018 - 10/2009
9AntigensIBA
07/2018 - 06/2008
8Histone Deacetylase InhibitorsIBA
01/2021 - 10/2011
7LigandsIBA
02/2022 - 05/2009
7Pharmaceutical PreparationsIBA
10/2021 - 02/2011
6Eph Family Receptors (Eph Receptors)IBA
02/2022 - 06/2010
6ParaffinIBA
10/2021 - 06/2008
5Histone Deacetylases (Histone Deacetylase)IBA
01/2021 - 02/2013
4EphrinsIBA
02/2022 - 06/2010
4Transcription Factors (Transcription Factor)IBA
09/2014 - 05/2009
4EnzymesIBA
02/2013 - 10/2009
3Glucose (Dextrose)FDA LinkGeneric
03/2019 - 01/2012
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
07/2018 - 01/2015
3Focal Adhesion Protein-Tyrosine KinasesIBA
01/2017 - 08/2010
3Messenger RNA (mRNA)IBA
01/2016 - 01/2015
3Retinoid X Receptors (Retinoid X Receptor)IBA
10/2015 - 05/2009
2Phenobarbital (Luminal)FDA Link
10/2021 - 07/2018
2Pregnane X ReceptorIBA
10/2021 - 10/2015
2Histones (Histone)IBA
01/2021 - 10/2011
2RNA (Ribonucleic Acid)IBA
11/2018 - 01/2015
2Antigen Receptors (Antigen Receptor)IBA
07/2018 - 01/2015
2PaxillinIBA
09/2017 - 01/2017
2Bile Acids and Salts (Bile Acids)IBA
05/2017 - 01/2012
2CannabinoidsIBA
03/2016 - 01/2016
2Antineoplastic Agents (Antineoplastics)IBA
01/2015 - 01/2014
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
11/2012 - 02/2011
2HomocysteineIBA
10/2012 - 07/2010
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
08/2012 - 08/2010
2PPAR gammaIBA
07/2011 - 05/2009
2Retinoid X Receptor alphaIBA
07/2011 - 05/2009
1CytokinesIBA
01/2022
1ELAV-Like Protein 1IBA
01/2022
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2022
1Formaldehyde (Formol)FDA Link
10/2021
1Anti-Bacterial Agents (Antibiotics)IBA
01/2021
1Carbonic Anhydrase IXIBA
03/2019
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
03/2019
1MicroRNAs (MicroRNA)IBA
11/2018
1RNA-Binding Proteins (RNA-Binding Protein)IBA
07/2018
1human ERBB2 proteinIBA
07/2018
1Progesterone Receptors (Progesterone Receptor)IBA
07/2018
1Estrogen ReceptorsIBA
07/2018
1CurcuminIBA
06/2018
1Carcinoembryonic AntigenIBA
11/2017
1CarbohydratesIBA
11/2017
1Calcibiotic Root Canal SealerIBA
09/2017
1Lipoproteins (Lipoprotein)IBA
05/2017
1ErbB Receptors (EGF Receptor)IBA
03/2017
1Cadherins (E-Cadherin)IBA
01/2017
1VimentinIBA
01/2017
1EndocannabinoidsIBA
01/2016
1Cannabinoid Receptors (Cannabinoid Receptor)IBA
01/2016

Therapy/Procedure

9Therapeutics
01/2022 - 07/2010
4Drug Therapy (Chemotherapy)
10/2021 - 03/2013
2Mediterranean Diet
04/2021 - 02/2018
2Radiotherapy
03/2019 - 01/2016
2Chemoprevention
08/2012 - 02/2011
1Oral Hygiene (Dental Hygiene)
07/2019
1Chemoradiotherapy
03/2019
1Duration of Therapy
06/2018
1Adjuvant Radiotherapy
01/2016